Skip to main content
OpenTrials
Completed

NCT Number: NCT06550817

Growth Mindset Intervention for Older Adults With Chronic Disease

This study was conducted to develop and investigate the effectiveness of a growth mindset intervention based on growth mindset theory.

Completed

Looking for future studies?

Notify Me

Key information

Age range

60 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

School of Medicine and Nursing, Huzhou University, Huzhou, Zhejiang, China

Loading trial locations.

About this study

The study employed a quasi-randomized controlled trial design conducted over 12 weeks. Before conducting the study, the researchers numbered the wards of internal medicine departments (excluding intensive care units) according to the order of bed number. The wards were then randomly divided into intervention wards and control wards using a random number generator. Patients were recruited to the control group (e-health only) in the control ward and the intervention group (growth mindset intervention+ e-health) in the intervention unit. Participants in the control group could undergo the training after the study concluded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • aged≥60 years
  • diagnosed≥1 chronic disease
  • owned at least one smartphone
  • could communicate clearly in writing or orally
  • were willing to participate in this study

Exclusion criteria

  • could not use WeChat or phone to communicate
  • diagnosed as mental illness or cognitive impairment
  • suffered from acute severe disease or lost self-care ability
  • undergoing other similar training

Treatment and study plan

Growth mindset intervention

Other

Online intervention is implemented and it lasts about 20 minutes each time, while face-to-face intervention lasts about 30 minutes each time, and they are carried out for a total of six weeks, face-to-face or telephone intervention is implemented once every two weeks for about 15 minutes each time

E-health Program

Other

face-to-face e-health teaching in the first 6 weeks, and telephone follow-up were conducted once a week, for about 10 minutes each time in the last 6 weeks

Primary outcomes

  1. Implicit Theories of Intelligence Scale-6

    Time frame: Baseline,Week 6, and Week 12

    The Implicit Theories of Intelligence Scale-6 (ITIS-6) is a validated, self-reported instrument assessing participants' level of growth mindset. A mean score of greater than or equal to 4 on all items indicates that the individual has a growth mindset, and vice versa for a fixed mindset.

  2. Questionnaire of Knowledge, Willingness, Confidence, and Practice of Smart Medicine (KWCP-SM)

    Time frame: Baseline,Week 6, and Week 12

    The Questionnaire of Knowledge, Willingness, Confidence, and Practice of Smart Medicine (KWCP-SM) is a validated, self-reported instrument assessing participants' level of knowledge, willingness, confidence, and practice of smart medicine. The questionnaire adopted the Likert-5 scoring method. The higher score indicated a higher level of knowledge, willingness, confidence, and practice of smart medicine.

Sponsors and collaborators

Lead sponsor

Huzhou University

Other

Registry information

Official study title

Growth Mindset Intervention Improves Positive Response to E-Health for Older Adults With Chronic Disease: A Randomized Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Aug 13, 2024
Registry last updated
Aug 13, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.